Influenza A virus

Influenza A virus
Hi Eun Jung and Heung Kyu Lee · CC BY 4.0 · source
Name	Influenza A virus
Virus group	Orthomyxoviridae
Genus	Alphainfluenzavirus
Family	Orthomyxoviridae
Genome	Negative-sense segmented RNA
Hosts	Humans, birds, mammals

Influenza A virus is a species of negative-sense, single-stranded RNA virus in the family Orthomyxoviridae that causes seasonal and pandemic respiratory disease across humans and multiple animal hosts. First isolated in the early 20th century during outbreaks that affected populations in London, New York City, and Madrid, it has been a central agent in major public health events such as the 1918 pandemic associated with high mortality across Paris and St. Petersburg. Influenza A virus interacts with global surveillance systems run by institutions like the World Health Organization and national agencies including the Centers for Disease Control and Prevention and Public Health England.

Taxonomy and Classification

Influenza A virus belongs to the genus Alphainfluenzavirus within the family Orthomyxoviridae. Its classification relies on antigenic properties of surface glycoproteins hemagglutinin and neuraminidase, which guide nomenclature used by reference laboratories in Atlanta and Geneva. The International Committee on Taxonomy of Viruses (ICTV), headquartered with ties to institutions in Zurich and Cambridge (UK), formally names species and strains in coordination with research centers such as the National Institutes of Health and the Pasteur Institute. Strain designation conventions are standardized across surveillance networks involving the European Centre for Disease Prevention and Control and the World Organization for Animal Health.

Virology and Genome Organization

The Influenza A virion is enveloped and displays surface proteins hemagglutinin (HA) and neuraminidase (NA), first characterized in seminal work from laboratories in Rockefeller University and the University of Cambridge. The segmented genome comprises eight negative-sense RNA segments encoding proteins including HA, NA, matrix protein M1, ion channel M2, nucleoprotein NP, and polymerase components PB1, PB2, and PA—genes mapped using techniques developed at the Sanger Institute and the Cold Spring Harbor Laboratory. Replication occurs in the nucleus of infected cells, a property examined in cell culture systems originating from collections at Madison and Boston. Structural biology studies resolved by teams at Harvard and Max Planck Institutes clarified HA and NA conformations that inform antiviral drug design at companies and agencies such as GlaxoSmithKline and the Food and Drug Administration.

Subtypes, Antigenic Drift and Shift

Influenza A viruses are divided into subtypes based on HA and NA combinations, historically cataloged following surveillance by centers in Tokyo and Seoul. Antigenic drift arises from accumulation of point mutations in HA and NA driven by host immune selection, a concept advanced by research groups at Oxford University and Johns Hopkins University. Antigenic shift, involving reassortment of genome segments between distinct strains, has led to pandemics traced to interspecies events often investigated by teams at the University of Wisconsin and the University of Hong Kong. Notable subtype transitions implicated in past pandemics were studied in archives housed in Boston and Stockholm.

Ecology and Reservoirs

Wild aquatic birds, particularly species studied by ornithologists at institutions like the Smithsonian Institution and the Natural History Museum, London, constitute the primary natural reservoir for Influenza A virus. Spillover into domestic poultry operations examined by researchers at the University of Arkansas and Wageningen University has produced epizootics controlled by veterinary bodies including the United States Department of Agriculture and the Royal Veterinary College. Mammalian hosts such as swine, horses, and marine mammals have served as intermediate or secondary hosts in events documented by field teams from Cornell University and the University of California, Davis.

Pathogenesis and Clinical Manifestations

In humans, infection triggers respiratory epithelial cell damage, inflammatory responses, and systemic symptoms characterized in clinical cohorts overseen by hospitals such as Mayo Clinic and Massachusetts General Hospital. Clinical manifestations range from uncomplicated influenza with fever and myalgia to severe pneumonia and acute respiratory distress syndrome managed in intensive care units in Berlin and Toronto. Complications include secondary bacterial pneumonia, exacerbations of chronic diseases first highlighted in epidemiologic studies by groups at Johns Hopkins and mortality patterns analyzed by demographers at the London School of Hygiene & Tropical Medicine.

Transmission, Epidemiology and Public Health Impact

Transmission occurs via respiratory droplets, fomites, and aerosol particles, with epidemiologic dynamics tracked through surveillance networks coordinated by the World Health Organization, CDC, and regional centers like the European Centre for Disease Prevention and Control. Seasonal epidemics impose morbidity and economic burden assessed in studies from Harvard School of Public Health and Imperial College London, while pandemics—such as those with origins investigated by teams in Beijing and Madrid—have reshaped health policy across nations including Italy and Australia.

Prevention, Treatment and Control Measures

Prevention centers on annual vaccination programs developed by manufacturers and evaluated in trials at AstraZeneca and academic centers like University College London. Antiviral treatments include neuraminidase inhibitors and polymerase inhibitors approved by regulatory agencies including the European Medicines Agency and the Food and Drug Administration. Nonpharmaceutical interventions implemented during outbreaks have been guided by policy research from the World Health Organization and national public health agencies including Public Health England and the CDC. Veterinary measures such as culling and biosecurity coordinated by the World Organisation for Animal Health reduce zoonotic risk.

Category:Viruses